Responses
Scientific Abstracts
Oral Presentations
Vaccination in rheumatic diseases with lessons from COVID
OP0192 SEROLOGICAL RESPONSE AND SAFETY OF A THREE-DOSE SARS-CoV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY
Compose a Response to This Article
Other responses
No responses have been published for this article.